Literature DB >> 20632436

Changing face of hepatic encephalopathy: role of inflammation and oxidative stress.

Amit S Seyan, Robin D Hughes, Debbie L Shawcross.   

Abstract

The face of hepatic encephalopathy (HE) is changing. This review explores how this neurocognitive disorder, which is associated with both acute and chronic liver injury, has grown to become a dynamic syndrome that spans a spectrum of neuropsychological impairment, from normal performance to coma. The central role of ammonia in the pathogenesis of HE remains incontrovertible. However, over the past 10 years, the HE community has begun to characterise the key roles of inflammation, infection, and oxidative/nitrosative stress in modulating the pathophysiological effects of ammonia on the astrocyte. This review explores the current thoughts and evidence base in this area and discusses the potential role of existing and novel therapies that might abrogate the oxidative and nitrosative stresses inflicted on the brain in patients with, or at risk of developing, HE.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20632436      PMCID: PMC2904880          DOI: 10.3748/wjg.v16.i27.3347

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  123 in total

1.  The effects of leucodepletion in patients who develop the systemic inflammatory response syndrome following cardiopulmonary bypass.

Authors:  D F Treacher; M Sabbato; K A Brown; V Gant
Journal:  Perfusion       Date:  2001-03       Impact factor: 1.972

2.  Rifaximin treatment in hepatic encephalopathy.

Authors:  Nathan M Bass; Kevin D Mullen; Arun Sanyal; Fred Poordad; Guy Neff; Carroll B Leevy; Samuel Sigal; Muhammad Y Sheikh; Kimberly Beavers; Todd Frederick; Lewis Teperman; Donald Hillebrand; Shirley Huang; Kunal Merchant; Audrey Shaw; Enoch Bortey; William P Forbes
Journal:  N Engl J Med       Date:  2010-03-25       Impact factor: 91.245

Review 3.  Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy.

Authors:  Jasmohan S Bajaj; James B Wade; Arun J Sanyal
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

4.  Indomethacin prevents the development of experimental ammonia-induced brain edema in rats after portacaval anastomosis.

Authors:  C Chung; J Gottstein; A T Blei
Journal:  Hepatology       Date:  2001-08       Impact factor: 17.425

5.  The systemic inflammatory response syndrome in acute liver failure.

Authors:  N Rolando; J Wade; M Davalos; J Wendon; J Philpott-Howard; R Williams
Journal:  Hepatology       Date:  2000-10       Impact factor: 17.425

6.  Regional cerebral blood flow autoregulation in patients with fulminant hepatic failure.

Authors:  F S Larsen; G Strauss; K Møller; B A Hansen
Journal:  Liver Transpl       Date:  2000-11       Impact factor: 5.799

Review 7.  Interaction of oxidative stress, astrocyte swelling and cerebral ammonia toxicity.

Authors:  Dieter Häussinger; Boris Görg
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-01       Impact factor: 4.294

8.  IL-1 or TNF receptor gene deletion delays onset of encephalopathy and attenuates brain edema in experimental acute liver failure.

Authors:  Chantal Bémeur; Hong Qu; Paul Desjardins; Roger F Butterworth
Journal:  Neurochem Int       Date:  2009-11-17       Impact factor: 3.921

Review 9.  Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis.

Authors:  Debbie L Shawcross; Shabnam S Shabbir; Nicholas J Taylor; Robin D Hughes
Journal:  Hepatology       Date:  2010-03       Impact factor: 17.425

10.  Minocycline attenuates oxidative/nitrosative stress and cerebral complications of acute liver failure in rats.

Authors:  Wenlei Jiang; Paul Desjardins; Roger F Butterworth
Journal:  Neurochem Int       Date:  2009-06-11       Impact factor: 3.921

View more
  36 in total

Review 1.  Advances in the evaluation and management of minimal hepatic encephalopathy.

Authors:  Jennifer Y Montgomery; Jasmohan S Bajaj
Journal:  Curr Gastroenterol Rep       Date:  2011-02

2.  Effects of SIBO and rifaximin therapy on MHE caused by hepatic cirrhosis.

Authors:  Yuying Zhang; Yikuan Feng; Bin Cao; Qiang Tian
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 3.  Management of covert hepatic encephalopathy.

Authors:  Abhijeet Waghray; Nisheet Waghray; Kevin Mullen
Journal:  J Clin Exp Hepatol       Date:  2014-04-01

Review 4.  Gut microbiota: its role in hepatic encephalopathy.

Authors:  Rahul Rai; Vivek A Saraswat; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2014-12-16

Review 5.  Minimal hepatic encephalopathy impairs quality of life.

Authors:  Swastik Agrawal; Sridharan Umapathy; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2014-12-04

6.  Gut microbiota, inflammation and hepatic encephalopathy: a puzzle with a solution in sight.

Authors:  Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2012-09

Review 7.  Gut microbiota and hepatic encephalopathy.

Authors:  Radha K Dhiman
Journal:  Metab Brain Dis       Date:  2013-03-06       Impact factor: 3.584

Review 8.  Perioperative nutritional therapy in liver transplantation.

Authors:  Ahmed Hammad; Toshimi Kaido; Shinji Uemoto
Journal:  Surg Today       Date:  2014-01-29       Impact factor: 2.549

9.  Neuropsychological functioning and health-related quality of life: pediatric acute liver failure study group results.

Authors:  Lisa G Sorensen; Katie Neighbors; Song Zhang; Christine A Limbers; James W Varni; Vicky L Ng; Robert H Squires; Estella M Alonso
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-01       Impact factor: 2.839

Review 10.  Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy.

Authors:  Halina Cichoż-Lach; Agata Michalak
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.